Skip to main content


Fig. 3 | Arthritis Research & Therapy

Fig. 3

From: Safety, tolerability, clinical, and joint structural outcomes of a single intra-articular injection of allogeneic mesenchymal precursor cells in patients following anterior cruciate ligament reconstruction: a controlled double-blind randomised trial

Fig. 3

Change from baseline in tibiofemoral joint space width over 24 months (medial joint space width (a) and lateral joint space width (b)) (mean and 95% confidence interval shown). HA hyaluronan, MPC mesenchymal precursor cell

Back to article page